BTLSB Stock Overview
An agricultural technology company, discovers and develops novel biological products in Belgium and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Biotalys NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.09 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0.93 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| BTLSB | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -3.9% | -0.4% |
| 1Y | n/a | -18.2% | 5.6% |
Return vs Industry: Insufficient data to determine how BTLSB performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how BTLSB performed against the UK Market.
Price Volatility
| BTLSB volatility | |
|---|---|
| BTLSB Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: BTLSB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BTLSB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 75 | Kevin Helash | www.biotalys.com |
Biotalys NV, an agricultural technology company, discovers and develops novel biological products in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; and BIOFUN-4 targeting oomycetes in fruits and vegetables.
Biotalys NV Fundamentals Summary
| BTLSB fundamental statistics | |
|---|---|
| Market cap | €87.15m |
| Earnings (TTM) | -€20.51m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-4.2x
P/E RatioIs BTLSB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BTLSB income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €20.51m |
| Earnings | -€20.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 22, 2024
| Earnings per share (EPS) | -0.64 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 11.3% |
How did BTLSB perform over the long term?
See historical performance and comparison